A Look at FDA's Proposed Changes to Labeling for Biosimilars and Interchangeable Biosimilars | Foley & Lardner LLP
The labeling of biosimilar products as “interchangeable” may be important in order to gain acceptance and use in the medical community. This article provides important information...